Johnson & Johnson Irish profits and revenues rise

Pre-tax profits at the Irish arm of the maker of such popular consumer health products as Calpol, Benylin, and Listerine increased by 3% to €5.3m in 2017.

Johnson & Johnson Irish profits and revenues rise

Pre-tax profits at the Irish arm of the maker of such popular consumer health products as Calpol, Benylin, and Listerine increased by 3% to €5.3m in 2017.

Newly filed accounts for Johnson & Johnson (Ireland) show the company’s revenues rose 2% to over €100.7m in 2017, the most recent year for which figures are available.

You have reached your article limit. Already a subscriber? Sign in

185 years of the Irish Examiner

185th
Anniversary Offer

Six months of digital access for €18.50

No obligation. Ts&Cs apply.

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited